BPH - Benign Prostatic Enlargement - Results from #40

REVIEW UroToday

A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence. August 30, 2024

Comparison of Clinical Therapeutic Efficacy between TUPKP and HoLEP for Patients Aged 70 Years and Older with Benign Prostatic Hyperplasia: Retrospective Study. August 26, 2024

Factors associated with concomitant prostate cancer in benign prostatic hyperplasia patients aged 60 years and above. August 26, 2024

Prostate-specific antigen, androgen, progesterone and oestrogen receptors in Benign prostatic hyperplasia: human tissues and animal model study. August 26, 2024

Predictive Factors for Tissue Inflammation in Patients with Benign Prostatic Hyperplasia (BPH): A Clinical Prediction Study. August 19, 2024

Multiparametric-magnetic resonance imaging (mp-MRI) of the prostate and Urolift: Identifying artefact size, location and clinical implications. August 19, 2024

The 'Prostate Embolisation AS first-line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial' (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH. August 18, 2024

UroLift to preserve seminal parameters in young male with LUTS from BPH. August 18, 2024

Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era. August 18, 2024

Comparison of Holmium and Thulium Laser Energy Effects on Prostate Enucleation: A Video Case Study August 16, 2024

Comparing embolic particles for prostatic artery embolization to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia. August 12, 2024

The early learning curve of the bipolar enucleation of the prostate: a multicenter cohort study. August 12, 2024

Risks and side effects in the medical management of benign prostatic hyperplasia. August 11, 2024

Does concordance between preoperatively measured prostate volume and enucleated weight predict outcomes in endoscopic enucleation of the prostate? Results from the REAP database. August 11, 2024

Androgen receptor deficiency-induced TUG1 in suppressing ferroptosis to promote benign prostatic hyperplasia through the miR-188-3p/GPX4 signal pathway. August 11, 2024

"Five-Step" Vaporization of the Prostate Using 180-W XPS Greenlight Laser in Patients with Benign Prostatic Hyperplasia of Large Volume: Improved Efficacy and Safety. August 5, 2024

Real-world experience with the new pulsed solid-state Thulium: YAG laser (Thulio) for endoscopic enucleation of the prostate. August 5, 2024

Advances in Outpatient Therapies and Treatment of Benign Prostatic Hyperplasia: A Comprehensive Review for Men's Health. August 2, 2024

Aquablation at 4-years: Real World Data from the Largest Single-Center Study with Associated Outcomes Follow-up. August 2, 2024

Assessment of prevalence of sexual dysfunction in patients having lower urinary tract symptoms with benign prostatic hyperplasia and effect of various treatment modalities on sexual function. August 2, 2024

Page 3 of 140